BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 30238143)

  • 1. Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system.
    Shi TQ; Huang H; Kerkhoven EJ; Ji XJ
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9541-9548. PubMed ID: 30238143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EasyCloneYALI: CRISPR/Cas9-Based Synthetic Toolbox for Engineering of the Yeast Yarrowia lipolytica.
    Holkenbrink C; Dam MI; Kildegaard KR; Beder J; Dahlin J; Doménech Belda D; Borodina I
    Biotechnol J; 2018 Sep; 13(9):e1700543. PubMed ID: 29377615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica.
    Schwartz C; Shabbir-Hussain M; Frogue K; Blenner M; Wheeldon I
    ACS Synth Biol; 2017 Mar; 6(3):402-409. PubMed ID: 27989123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed CRISPR Activation of Cryptic Sugar Metabolism Enables Yarrowia Lipolytica Growth on Cellobiose.
    Schwartz C; Curtis N; Löbs AK; Wheeldon I
    Biotechnol J; 2018 Sep; 13(9):e1700584. PubMed ID: 29729131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic biology tools for engineering Yarrowia lipolytica.
    Larroude M; Rossignol T; Nicaud JM; Ledesma-Amaro R
    Biotechnol Adv; 2018 Dec; 36(8):2150-2164. PubMed ID: 30315870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving CRISPR/Cas9-mediated genome editing efficiency in Yarrowia lipolytica using direct tRNA-sgRNA fusions.
    Abdel-Mawgoud AM; Stephanopoulos G
    Metab Eng; 2020 Nov; 62():106-115. PubMed ID: 32758536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic engineering in the host Yarrowia lipolytica.
    Abdel-Mawgoud AM; Markham KA; Palmer CM; Liu N; Stephanopoulos G; Alper HS
    Metab Eng; 2018 Nov; 50():192-208. PubMed ID: 30056205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system.
    Gao S; Tong Y; Wen Z; Zhu L; Ge M; Chen D; Jiang Y; Yang S
    J Ind Microbiol Biotechnol; 2016 Aug; 43(8):1085-93. PubMed ID: 27349768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Yarrowia lipolytica as a superior biomanufacturing platform by tuning gene expression using promoter engineering.
    Sun ML; Shi TQ; Lin L; Ledesma-Amaro R; Ji XJ
    Bioresour Technol; 2022 Mar; 347():126717. PubMed ID: 35031438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic engineering of Yarrowia lipolytica for industrial applications.
    Zhu Q; Jackson EN
    Curr Opin Biotechnol; 2015 Dec; 36():65-72. PubMed ID: 26319895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of YALIcloneHR toolkit for Yarrowia lipolytica combined with Golden Gate and CRISPR technology.
    Shen Q; Yan F; Li YW; Wang J; Ji J; Yan WX; He DC; Song P; Shi TQ
    Biotechnol Lett; 2024 Feb; 46(1):37-46. PubMed ID: 38064043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Tools for Streamlined and Accelerated Pathway Engineering in Yarrowia lipolytica.
    Wong L; Holdridge B; Engel J; Xu P
    Methods Mol Biol; 2019; 1927():155-177. PubMed ID: 30788791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Biology Expands the Industrial Potential of Yarrowia lipolytica.
    Markham KA; Alper HS
    Trends Biotechnol; 2018 Oct; 36(10):1085-1095. PubMed ID: 29880228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and opportunities in gene editing and gene regulation technology for Yarrowia lipolytica.
    Ganesan V; Spagnuolo M; Agrawal A; Smith S; Gao D; Blenner M
    Microb Cell Fact; 2019 Nov; 18(1):208. PubMed ID: 31783869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golden Gate-based metabolic engineering strategy for wild-type strains of Yarrowia lipolytica.
    Egermeier M; Sauer M; Marx H
    FEMS Microbiol Lett; 2019 Feb; 366(4):. PubMed ID: 30698703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yarrowia lipolytica: recent achievements in heterologous protein expression and pathway engineering.
    Madzak C
    Appl Microbiol Biotechnol; 2015 Jun; 99(11):4559-77. PubMed ID: 25947247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in synthetic biology of oleaginous yeast Yarrowia lipolytica for producing non-native chemicals.
    Darvishi F; Ariana M; Marella ER; Borodina I
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):5925-5938. PubMed ID: 29808327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
    Mitsui R; Yamada R; Ogino H
    World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.